Ovintiv Inc. (OVV)

Positive revenue growth while CVE is negative. John Neff might see a notable competitive edge here.

Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.

Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.

Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.

Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.

Maintaining or increasing dividends while CVE cut them. John Neff might see a strong edge in shareholder returns.

OCF growth 1.25-1.5x CVE's 80.53%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.

Positive 10Y revenue/share CAGR while CVE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.

Positive 5Y CAGR while CVE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.

Positive 3Y CAGR while CVE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.

Positive long-term OCF/share growth while CVE is negative. John Neff would see a structural advantage in sustained cash generation.

5Y OCF/share CAGR above 1.5x CVE's 100.00%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.

Positive 3Y OCF/share CAGR while CVE is negative. John Neff might see a big short-term edge in operational efficiency.

Positive 10Y CAGR while CVE is negative. John Neff might see a substantial advantage in bottom-line trajectory.

5Y net income/share CAGR 1.25-1.5x CVE's 100.00%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.

Positive short-term CAGR while CVE is negative. John Neff would see a clear advantage in near-term profit trajectory.

Positive growth while CVE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.

Positive 5Y equity/share CAGR while CVE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.

Positive short-term equity growth while CVE is negative. John Neff sees a strong advantage in near-term net worth buildup.

Stable or rising dividend while CVE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.

Dividend/share CAGR of 93.57% while CVE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.

Our short-term dividend growth is positive while CVE cut theirs. John Neff views it as a comparative advantage in shareholder returns.

Our AR growth while CVE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.

Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.

Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.

No Data available this quarter, please select a different quarter.

We expand SG&A while CVE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.